While LPS exposure alone resulted in a 59% increase in oxidized DCF (a measure of ROS) compared to control cells, pretreatment with GHK-Cu at concentrations of 1, 5, and 10 M significantly decreased ROS production
Data collected in laboratory settings by Khorram et al
Minor side effects may include: Mild soreness at the injection site Temporary dizziness or nausea (rare) Avoid overuse, and ensure your therapy is administered by a certified medical professional
This decline coincides with reduced regenerative capacity, prompting researchers to investigate its potential for supporting skin health
Our team ensures the procedure is safe, effective, and tailored to deliver optimal results
Its often sourced from unregulated suppliers